FVIII:C Deficient Plasma (1 × 1 mL) — <1% Residual
Product DescriptionFor Research Use Only. Not for Use in Diagnostic Procedures. Lyophilized human citrated plasma immunodepleted for Factor VIII (FVIII). Residual FVIII activity <1%. CE-IVD. 1 × 1 mL. Primary substrate for hemophilia A one-stage FVIII activity assay. Used in combination with CEPHEN™ APTT reagent — the absence of FVIII causes prolonged APTT inversely proportional to FVIII in the test sample. Essential for hemophilia A diagnosis, monitoring replacement therapy, recombinant FVIII product potency, and inhibitor assay substrate.
Product Characteristics
Product Components
|
Product ApplicationsFor measurement of Factor VIII:C (FVIII:C) activity in research applications. For any in vitro protocol or research study where a source of human FVIII:C deficient plasma is required. Associated calibrator and controls are available: BIOPHEN Plasma Calibrator (Ref A222101-RUO), BIOPHEN Normal Control Plasma (Ref A223201-RUO) and BIOPHEN Abnormal Control Plasma (Ref A223301-RUO). Certificate of Analysis (COA) |
FVIII:C Deficient Plasma (1 x 1 mL) - RUO